Related Experiment Video
Updated: May 27, 2026
Mechanical Vessel Injury in Zebrafish Embryos
Published on: February 17, 2015
Using zebrafish (Danio rerio) to assess gene function in thrombus formation
Christopher M Williams1, Alastair W Poole
1Department of Physiology & Pharmacology, School of Medical Sciences, University of Bristol, Bristol, UK.
Insights
Cardiovascular diseases are a major cause of death. This study explores the zebrafish model for effective screening of novel genes involved in platelet function and thrombosis, aiding vascular disease management.
Area of Science:
- Cardiovascular research
- Thrombosis and hemostasis
- Zebrafish genetics
Background:
- Cardiovascular and cerebrovascular diseases are leading causes of death globally.
- Platelets are key targets for managing vascular diseases, but antithrombotics can cause bleeding side effects.
- Current mouse models for gene function studies are costly and may not guarantee relevant phenotypes.
Purpose of the Study:
- To highlight the zebrafish as a suitable model for studying thrombosis.
- To discuss current techniques for assessing gene function in zebrafish thrombosis models.
- To propose a framework for constructing an effective genetic screen for thrombosis-related genes.
Main Methods:
- Review of existing literature on zebrafish models for thrombosis research.
- Discussion of techniques for gene function assessment in zebrafish.
- Conceptualization of a genetic screening strategy.
Main Results:
- Zebrafish offer a viable alternative model for thrombosis research.
- Established and emerging techniques allow for gene function analysis in zebrafish.
- A genetic screening approach can be developed for novel gene discovery.
Conclusions:
- Zebrafish provide a powerful platform for understanding platelet function and thrombosis.
- This model facilitates the identification of new therapeutic targets for vascular diseases.
- Developing effective genetic screens in zebrafish is crucial for advancing cardiovascular research.
Abstract:
Cardiovascular and cerebrovascular disease is the major cause of death in the developed world, with a high burden of disease and substantial pharmaceutical investment to manage it (WHO, Global Burden of Disease, 2004 Update, W.H. Organisation, Editor. 2008). Platelets, as the principal mediators of thrombus formation, are a primary pharmaceutical target, with attenuation of platelet function and thrombus formation significantly reducing the incidence of myocardial infarction and stroke. Haemostasis, however, may also be affected by antithrombotics, leading to spontaneous and/or prolonged bleeding as a potentially severe side effect. Developing a comprehensive understanding of the mechanisms involved in platelet function and thrombus formation is anticipated to identify drug targets that may effectively manage vascular disease without an impact on haemostasis. Despite the progress in characterising individual genes in platelet function and thrombosis, using gene knockout and transgenic mice over the past decade or so, there is still much to be uncovered. Investigating gene function using mouse models is a substantial investment and a considerable amount of work, with a relevant phenotype not guaranteed. As such, a new model is needed for the effective screening of novel genes that have been identified as having potential roles in platelet function or cardiovascular disease by genomic association and comparative expression studies (Nature, 447(7145): 661-678, 2007; Nat Genet, 41(11): 1182-1190, 2009; N Engl J Med, 357(5): 443-453, 2007; Blood, 109(8): 3260-3269, 2007). Here, we highlight and discuss the relevance of the zebrafish (Danio rerio) as a model for studying thrombosis, the current techniques that are employed to assess gene function in a zebrafish model of thrombosis, and how an effective genetic screen may be constructed.
